Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.04% Nasdaq Down 0.65%
Streaming
Ticker Tape: On

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
53.74 Down 1.28(2.33%) 3:13PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:55.02
Open:54.96
Bid:53.43 x 200
Ask:53.54 x 200
1y Target Est:100.71
Beta:2.01
Earnings Date:May 5 - May 9 (Est.)
Day's Range:52.91 - 55.51
52wk Range:32.22 - 93.33
Volume:349,599
Avg Vol (3m):607,155
Market Cap:1.82B
P/E (ttm):N/A
EPS (ttm):-2.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSDown 2.33%1.82B
IMMUDown 8.97%346.52M
LRUSFUp 0.42%56.37M
THLDDown 5.26%244.56M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.88
Quarterly EPS Est (Mar-14) :-0.85
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback